Table 4. F. alocis D-62D— extracellular fraction.
Spot | Accessiona) | Protein descriptiona) | Mol. wt/Cal- culated mol. wt (kDa) |
PMF scoreb)/ (emPAl) |
Total peptides matchedc) |
PSORT prediction score and categoryd) |
Domainse) | HI scoref) |
Nature of proteing) |
---|---|---|---|---|---|---|---|---|---|
1. | HMPREF0389_01110 | Cell wall associated serine proteinase | 262 | 29/0.01 | 32 | CM-9.39 EC-0.61 |
Membrane lipid attachment domain | 1.61 | N terminal signal peptide |
2. | HMPREF0389_01728 | Conserved hypothetical protein | 246.5 | 25/0.04 | 4 | EC-4.32 CW-5.69 |
Peptidoglycan anchor domain | 1.37 | N terminal signal peptide |
3. | HMPREF0389_01692 | Hypothetical protein | 223 | 98/0.16 | 4 | C-7.50 EC-0.73 |
Hemolysin III type calcium-binding signature domain Inorganic pyrophosphate domain | – | Nonsecretory |
4. | HMPREF0389_01419 | Conserved hypothetical protein | 145.2 | 43/0.11 | 7 | C-7.5 EC-0.73 |
DNA-binding domain | – | Nonsecretory |
5. | HMPREF0389_01687 | Pyruvate-flavodoxin oxidoreductase | 130 | 156/0.29 | 45 | C-7.50 EC-0.73 |
4 Fe-4S ferredoxin-type iron–sulfur binding domain | 1.86 | N terminal signal peptide |
6. | HMPREF0389_01448 | Calcium-binding acid repeat protein | 103 | 25/020 | 16 | Unknown | SLH domains-3 numbers | 2.0 | N terminal signal peptide |
7. | HMPREF0389_00724 | ATP-dependent chaperone protein | 97.5 | 902/0.68 | 45 | C-9.97 EC-0.02 |
Chaperonin cIpA/B signature domain | – | Nonsecretory |
8. | HMPREF0389_01431 | Conserved hypothetical protein | 97.5 | 21/0.07 | 4 | EC-2.92 | Precursor signal domain | 1.02 | N terminal signal sequence |
9. | HMPREF0389_00122 | Protease | 88.5 | 32/0.10 | 7 | EC-0.73 | Peptidase collagenase family domain | – | Nonsecretory |
10. | HMPREF0389_00279 | ATP-dependent protease La | 87.9 | 26/0.07 | 5 | C-9.97 EC-0.02 |
Serine protease La binding domain | – | Nonsecretory |
11. | HMPREF0389_000638 | Membrane protein | 80.45 | 18/0.11 | 6 | M | Membrane protein precursor signal | – | |
12. | HMPREF0389_01580 | Leucotoxin translocation ATP-binding protein | 81.1 | 59/0.09 | 8 | CM-10 | Peptidase C-39, ABC transporter 2 domains | – | Nonsecretory |
13. | HMPREF0389_01452 | Conserved hypothetical protein | 76.8 | 12/0.05 | 3 | CM-9.87 EC-0.03 |
S-layer precursor signal domain | 2.32 | N terminal signal peptide |
14. | HMPREF0389_01452 | Conserved hypothetical protein | 76.8 | 16/0.07 | 3 | CM-9.8 EC-0.12 |
S-layer precursor signal domain | 2.32 | N terminal signal peptide |
15. | HMPREF0389_01750 | Hypothetical protein | 71/69.8 | 22/0.05 | 8 | 3.10C 1.05 M |
Collagen-binding protein B domain | 0.12 | Nonsecretory protein |
16. | HMPREF0389_00315 | Conserved hypothetical protein | 70.7 | 138/0.08 | 6 | C-7.5 EC-0.75 |
Secretory system-2 pilus domain | – | Nonsecretory |
17. | HMPREF0389_00315 | Conserved hypothetical protein | 70.7 | 35/0.11 | 4 | C-7.50 EC-0.73 |
Secretory system-2 pilus domain | – | Nonsecretory |
18. | HMPREF0389_00575 | Fibronectin-binding protein | 68.1 | 102/0.25 | 12 | C-7.50 EC-0.73 |
Protein A binding adherence fibronectin/fibrinogen domain | – | Nonsecretory |
19. | HMPREF0389_00223 | S layer Y containing domain | 66.7 | 651/0.69 | 22 | CW-9.2 EC-0.78 |
S layer homology domain | 1.88 | N terminal single peptide |
20. | HMPREF0389_01573 | V-type ATP synthetase alpha chain | 66.4 | 21/0.09 | 3 | C-9.97 | ATP-binding V type domain | – | Nonsecretory |
21. | HMPREF0389_00803 | Conserved hypothetical protein | 63.8 | 30/0.05 | 4 | Unknown | Histidine kinase domain | – | Nonsecretory |
22. | HMPREF0389_00261 | Conserved hypothetical protein | 62.9 | 17/0.07 | 4 | Unknown | EF-hand calcium-binding domain | – | Nonsecretory |
23. | HMPREF0389_00804 | Oligopeptide-binding protein | 60.25 | 27/0.07 | 7 | EC-0.91 | Lipid attachment domain at two positions | 2.26 | N terminal signal peptide |
24. | HMPREF0389_01605 | Formate tetra hydrofolate ligase | 60.17 | 16/0.07 | 3 | C-7.0 EC-0.73 |
FTH dignature domain | – | Nonsecretory |
25. | HMPREF0389_00868 | DAK 2 domain protein | 58.8 | 11/0.06 | 2 | C-7.50 EC-0.73 |
DhaL profile domain | – | Nonsecretory |
26. | HMPREF0389_00596 | UDP-N-muramyl tripeptide synthetase | 57.06 | 145/0.13 | 16 | C-7.50 EC-0.73 |
Cell wall tripeptide synthetase domain | – | Nonsecretory |
27. | HMPREF0389_00480 | Amido transferase family protein | 54.7 | 345/0.54 | 34 | C-7.5 EC-0.73 |
GATB domain | – | Nonsecretory |
28. | HMPREF0389_01130 | Ferrous hydrogenase | 54.3 | 32/0.07 | 3 | C-7.5 EC-0.73 |
Ferrodoxin type Fe-S binding domain | 1.88 | N terminal signal peptide |
29. | HMPREF0389_01374 | Conserved hypothetical protein | 48.5 | 52/0.07 | 6 | C-9.5 EC-0.2 |
YNIH -BH1805-YDJI domain | – | Nonsecretory |
30. | HMPREF0389_00504 | Peptidase U32 family protein | 47.7 | 22/0.09 | 7 | C-7.50 EC-0.73 |
Peptidase U 32 domain | – | Nonsecretory |
31. | HMPREF0389_01584 | Arginine deiminase | 46.6 | 23/0.07 | 12 | C-7.5 EC-0.73 |
Arginine deiminase domain | Nonsecretory | |
32. | HMPREF0389_01344 | NLP/P60 domain protein | 45.4 | 26/0.07 | 8 | EC-9.60 C-0.15 |
G5 domain | – | Nonsecretory |
33. | HMPREF0389_01570 | Acetyl ornithine transaminase | 43.5 | 195/0.44 | 16 | C-9.97 EC0.02 |
AA transfer class 3 domain | – | Nonsecretory protein |
34. | HMPREF0389_00538 | Processive diacylglycerol glucosyl transferase | 42.2 | 11/0.05 | 2 | Unknown | MGDG domain | – | Nonsecretory |
35. | HMPREF0389_01465 | Conserved hypothetical protein | 41.5 | 29/0.13 | 4 | C-7.5 EC-0.73 |
Hydrolase domain | – | Nonsecretory |
36. | HMPREF0389_00744 | Butryl coA dehydrogenase | 41.25 | 11/0.07 | 2 | C-7.5 EC-0.73 |
Acetyl coA DH1 and DH2 domain | – | Nonsecretory |
37. | HMPREF0389_00745 | Acetyl coA acetyl transfserase | 40.9 | 51/0.07 | 9 | C-7.2 EC-0.93 |
Thiolase 1,2,3 domain | – | Nonsecretory |
38. | HMPREF0389_01008 | Membrane lipoprotein | 39.54 | 39/0.06 | 5 | Unknown | N terminal lipoprotein lipid attachment domain | 2.31 | N terminal signal peptide |
39. | HMPREF0389_01567 | N acetyl gamma glutamyl phosphate reductase | 38.7 | 79/0.34 | 13 | Unknown | NAC gama glutamyl phosphate domain | – | |
40. | HMPREF0389_01445 | O-Sialoglycoprotein endo peptidase. | 36.6/36.2 | 22/0.55 | 5 | 1.806 C 1.17M 1.17M |
Metal-dependent protease-molecular chaperone domain | –0.45 | Potent cleavage site without N terminal signal sequence |
41. | HMPREF0389_00940 | Phosphate acetyl transferase | 36.0 | 26/0.11 | 2 | C-7.5 EC-0.73 |
Acetyl transferase metal binding domain | – | Nonsecretory |
42. | HMPREF0389_00704 | TRAP transporter solute receptor protein | 35.9 | 344/0.30 | 16 | Unknown | Membrane lipoprotein lipid attachment domain | 1.12 | N terminal signal peptide |
43. | HMPR45EF0389_01401 | Conserved hypothetical protein | 34.9 | 30/0.09 | 6 | EC-0.73 | Precursor signal YQFA trans membrane domain | 3.67 | Strong N terminal signal peptide |
44. | HMPREF0389_00901 | Cobalt import ATP-binding protein | 33.92 | 22/0.08 | 8 | CM-8.79 EC-0.09 |
CBIO and ATP transporter domain | – | Nonsecretory |
45. | HMPREF0389_01198 | L-aminopeptidase | 33.3 | 12/0.09 | 4 | C-7.50 EC-0.73 |
Peptidase DMPA hydrolase domain | – | Nonsecretory |
46. | HMPREF0389_01569 | Acetyl glutamate kinase | 31.03 | 741/2.34 | 59 | EC-0.73 | Arginine amino acid kinase | – | |
47. | HMPREF0389_01545 | Copper amine oxidase N-domain protein | 30.5 | 22/0.09 | 6 | Unknown | Precursor signal domain | 1.96 | N terminal signal sequence |
48. | HMPREF0389_01619 | Iron-sulfur cluster-binding protein | 29.1 | 24/0.51 | 2 | C-7.5 EC-0.73 |
4Fe-4S-ferredoxin type iron-sulfur binding domain | – | Nonsecretory |
49. | HMPREF0389J582 | Phosphoglycerate mutase | 29.1 | 45/0.56 | 7 | C-6.23 | PGAM domain | – | Nonsecretory |
50. | HMPREF0389_00100 | Glutamate racemase | 29.4 | 47/0.06 | 10 | EC-0.75 C-3.45 | Aspartate glutamate racemase signature | – | |
51. | HMPREF0389_01471 | Glutaconyl coA decarboxylase | 29.4 | 383/0.22 | 18 | CM | Acetyl CoA CT- N and C terminal domains | – | |
52. | HMPREF0389_00119 | Pyrroline-5-carboxylate reductase | 28.8 | 10/0.07 | 2 | C-9.95 | P5CR domain | – | Nonsecretory |
53. | HMPREF0389_00743 | Electron transfer flavoprotein beta | 28.2 | 26/0.12 | 3 | EC-0.73 C-6.32 |
ET-Flavoprotein beta domain | – | |
54. | HMPREF0389_01259 | Histidinol phosophatase | 25.2 | 36/0.10 | 3 | C-7.50 EC-0.73 |
PHP-C terminal domain | – | Nonsecretory |
55. | HMPREF0389_00321 | Conserved hypothetical protein | 23.9 | 21/0.10 | 4 | Unknown | No conserved domain | 2.01 | N terminal signal peptide |
56. | HMPREF0389_00975 | TetR family transcriptional regulator | 22.8 | 65/0.12 | 6 | C-7.50 EC-0.73 |
HTH-TETR-2 domain | – | Nonsecretory |
57. | HMPREF0389_01744 | Conserved hypothetical protein | 22.7 | 11/0.09 | 2 | C-7.5 EC-0.73 |
Uncharacterized domain | – | Nonsecretory |
58.h) | HMPREF0389_01071 | Tetracyclin resistant protein | 20.8 | 34/0.11 | 4 | C-7.50 EC-0.73 |
No conserved domain | – | Nonsecretory |
59.h) | HMPREF0389_01503 | Conserved hypothetical protein | 15.7 | 11/0.07 | 2 | Unknown | No conserved domain | – | Nonsecretory |
60.h) | HMPREF0389_01654 | Neutrophil-activating factor protein A | 14/16.2 | 12/0.07 | 2 | 2.310 C 0.099 M |
DPS domain | 0.32 | Nonsecretory |
61.h) | HMPREF0389_01741 | Conserved hypothetical protein | 8.7 | 32/0.07 | 2 | Unknown | No conserved domain | – | Nonsecretory |
Accession numbers and protein descriptions are from the NCBI F alocis genome project (http://www.ncbi.nlm.nih.gov/genomeprj/46625).
Peptide mass fingerprinting score from Mascot.
Number of matched peptides derived from Mascot.
Psortb prediction score classifying protein as: C, cytoplasmic; CM, cytoplasmic membrane; M, membrane; CW, cell wall; PP, periplasm; Ex, extra cellular. Non classical secretory protein in silico prediction through “Secretome.”
Conserved domain prediction using the NCBI-Conserved domain database search.
Hydropathy index (HI) score from the iPsort predictions on the nature of protein, high positive score indicate presence of a signal sequence negative scores predict proteins as non secretory.
iPsort prediction showing protein to contain signal sequence, cleavage site and classification of protein to be secretory or nonsecretory.
Low molecular weight protein spots not clearly seen in Fig. 6 but confirmed by MS analysis.